MAGNETOM Lumina and MAGNETOM Vida Fit with syngo MR XA50A
Siemens Medical Solutions USA Inc. • Radiology • 04/29/2022
Device Purpose
The MAGNETOM Lumina and MAGNETOM Vida Fit systems with syngo MR XA50A software are magnetic resonance diagnostic devices designed to enhance diagnostic imaging and interventional capabilities through new hardware such as the Nexaris Dockable Table and Beat Sensor, and advanced software features including deep learning-based image reconstruction and specialized automated workflows. These innovations aim to improve image quality, reduce scan times, and streamline complex imaging procedures for various anatomical regions and clinical scenarios.
Summary
The MAGNETOM Lumina and MAGNETOM Vida Fit systems, when upgraded with syngo MR XA50A software, function as advanced magnetic resonance diagnostic devices (MRDD). They are designed to produce a comprehensive range of images, including transverse, sagittal, coronal, and oblique cross-sections, as well as spectroscopic images and spectra, for visualizing the internal structure and function of the head, body, or extremities. These systems can derive other physical parameters from the acquired data, may utilize contrast agents, and support imaging during interventional procedures with MR-compatible devices, thereby assisting physicians in diagnosis. The syngo MR XA50A software introduces significant hardware and software enhancements. For the MAGNETOM Vida Fit, new hardware includes the Nexaris Dockable Table for interventional and diagnostic imaging, the Nexaris Head Frame, the Nexaris Spine 36 coil, and a contactless Beat Sensor for cardiac triggering. Software updates common to both Lumina and Vida Fit models feature Deep Resolve Swift Brain for rapid brain imaging using EPI and deep learning reconstruction, Deep Resolve Boost for deep learning-based 2D TSE image reconstruction, and BLADE diffusion and HASTE diffusion for improved diffusion-weighted imaging with reduced artifacts. Other notable software additions include SVS_EDIT and GRE_WAVE pulse sequences (Vida Fit), Compressed Sensing GRASP-VIBE for liver exams in patients with breath-holding difficulties (Lumina), injector coupling (Vida Fit), myExam Prostate Assist (Vida Fit), and myExam Angio Advanced Assist for guided workflows, alongside various motion correction and image enhancement tools.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the 'Deep Resolve Swift Brain' protocol compare to conventional brain imaging protocols in terms of acquisition time, image quality, and diagnostic accuracy for common neurological conditions?; What is the quantitative impact of the 'Beat Sensor' on cardiac MRI workflow efficiency and image quality compared to traditional ECG or pulse gating, particularly in patients with arrhythmias?; Can the 'Compressed Sensing GRASP-VIBE' technique maintain diagnostic image quality for liver lesions in patients with severe breath-holding incapacity, and how does its sensitivity compare to standard breath-hold sequences?; What specific improvements in slice angulation and coverage reproducibility does the 'myExam Prostate Assist' offer, and how does this translate to reduced scan repetitions or improved diagnostic confidence in prostate MRI?; How does the 'Nexaris Dockable Table' system integrate with existing operating room or interventional suite setups, and what are the time savings or workflow improvements observed during patient transfer for intraoperative MRI?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly